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The report by Buxton et al. (1) in this issue of the Journal 
addresses significant issues in clinical electrophysiology, 
namely, the importance of polymorphic ventricular tachy- 
cardia induced by programmed stimulation and its moditica- 
tion by the type IA drug pmcainamide. In a large series of 
patients in whom programmed stimulation induced polymor- 
phic ventricular tachycardia in the absence of antiarrhythmic 
drugs, the intravenous administration of pmcainamide re- 
sulted in the induction of monomorphic ventricular tach;- 
cwdia in 30% of patients and the persistent induction of 
polymorphic ventricular tachycardia in 38%: it prevented the 
induction of either tachycardia in the remaining 32%. The 
vast majority of patients with a mono~:torphic tachycardia 
after pmcainamide administration had coronary artery dis- 
ease with previous mywardial infarction and the abnonnal- 
ities of the signal-averaged electrocardiogram (EC@ and left 
ventricular endocardial electrograms commonly seen in 
patients with spontaneous or inducible monomorphic ven- 
tricular tachycwdia. In a few patients in this group the 
conversion of polymorphic to monomorphic ventdcsler 
tachycardia by pr oainamide permitted mappiog of the ven- 
tricular activation pattern of the tachycardia and allowed 
successful application of surgical OT catheter ablative them 
patic techniques that would otherwise not have been pos- 
sible in these patients. A rather impoi-lant conclusion wes 
that tile prevention of the induction of polymorphic ventric- 
ular tachycerdia by pnxainamide cannot be &&tied as a 
favorable response because three of four patients in this 
group who bad originally presented with cardiac arrest bad 
recurrent arrest during treatment with this drug. In addition 
to the small number of patients who underwent antianhyth- 
mic ablative therapy, the majority of patients had individu- 
a!i;ed treatment with drugs or implantation of an automatic 
cardioverter-defib~l~tor, or both. Because management in 
thic study was not performed onder controlled condition, 
only limited conclusions regarding the value of these obser- 
vzions we possible. However, the study serves as a re- 
minder of the empiric nature of some of the concepts 
underlying the use of programmed stimuIati@n to guide 
therapeutic strategies in patients susceptible to malignant 
ventricular tachy~ytbmias. 
Si~R of induced SrmS 
ventricutar tachycwdia. Progmmmed stimulation is com- 
monly utilized to guide therapeutic suategies in patients with 
suspected or documented symptomatic ventricular tachyar- 
rhythmia. When a sustained monomorphic ventricular 
tachycardia is induced, the finding of an antiarhytbmic 
drug, or a combination of drugs, that can prevent its induc- 
tion. or at least slow its rate so that the patient’s condition 
becomes hemodynamically more stable, is cwsidered a 
satisfactory end point; patients are then maintained on 
treatment with those drugs (2-4). Several clinical serieshave 
shown that such patients have significantly fewer episodes of 
symptomatic ventricular tachyarrhytlmda or sudden cardiac 
death, or both, than do patients in whom tto “successful” 
drug regimen is found (S,6). However, no well contrdkd 
randomized published study has documented the validity of 
this aooroach. Tix problem in contemww clinica! elec- 
troph&iology see& to have less to do with the index of 
electrical instability (that is, the surrogate arrhythmias in- 
duced by programmed stitntdation or the spontaneous ar- 
rhytbmias seen ~1 long-term ambulatory ECG monitoring) 
than with the availability or lack of an effective aotiarrhyth- 
mic drug. Because most type I drugs can have signiticant 
proarrhythmic effects, a favorable balance between a poten- 
:ial beneficial etTect and a possible deleterious etTect should 
always be sought. Unfortunately, with our current knowl- 
edge, this balance is usually diBicult to predict. before 
treatment in dierent groups ofpatients, not to mention inan 
individual patient. 
The prognosric significance ofinducedpolymorphic ven- 
tricular rachycardia is more controversial and seems to 
depend largely on the clinical presentation. Unfortunately, 
the report by Buxton et al. (1) pmvides only meager details 
of the clinical presentation of their patients and its intluence 
on their therapeutic strategy. In addition, induced wnsus- 
tained and walled sustained polymorphic ventricular 
tachycardia are lumped together. In fact, there is no general 
agree.eent on the definition of sustained spontaneous or 
induced polymorphic ventricular tachycardia. A sustained 
polymorphic ventricular tachycardia defined as having an 
avera rate 8120 beats/min and lastiw a30 s (that is, 
similar to the accepted definition of sustained monomorphic 
ventricular tachycardia) is uncommon. in contrast, inducible 
polymorphic ventricular tachycardia that requires prompt 
cardioversion because of hemodynamic collapse probably 
diffeers little from ventricular fibrillation. For this reason. it is 
tions that are suppressed by the drug, allowing the expres- 
sion of a recntmnt monomorphic tachycardia. However, a 
more plausible explanation, is that both &morphic and 
monomorphic ventricular tachycardias are due to reentrant 
excitation. Procainamidc can lengthen refractoriness or slow 
conduction, or both, in smne critical components of the 
reentrant circuit as well 8s oppose the known tendency of 
refractoriness to shorten in an inhomogeneous fashion in 
ischcmic hearts in response to successive short cardiac 
cycles. This action could presumably stabilize reentrant 
excitation around one constant pathway. This effect is 
expected to be seen more often in bats that have the 
ana:omic-elenrophysiologic substrate commonly associated 
with spontaneous or induced monomorphic ventricular 
tachycardia. 
vation mapping and possible application of ablative them 
peutic techniques. The prevention of induction of polymor- 
phic ventricular tachycardia by the drug dws not seem to he 
Conc1usiom. At present, the modulation of induced poly- 
morphic ventricular tachycardia by procainamide has little 
clinical value except in the small number of patients i  whom 
the drug can help to induce a hemodynamically stable 
monomorphic vcntriculsr tachycardia, thus pemdtting acti- 
customary to consider induced polymorphic vcntricuiar 
Is there a difference between palymorphk ventrkular 
tachyerrhytirmia  valid end paint in patients with docu- 
tachycardis and tmsade de p&w tachycwdia? There is 
mented reswcitation from ventricular fibrillation or with a 
high likelihood of having had such an arrhythmia (5). At 
present, such patients are more likely to be candidates for 
unnecessary confusion regarding the use of these two terms. 
the implantable cardioverter-defibrillator than for serial anti- 
arhythmic drug hials. Conversely, in patients with no such 
history, the induction of a polymorphic ventricular tachyar- 
rhythmia is considered a nonclinical response to pro- 
grammed stimulation that lacks prognostic significance (731, 
partimtarly if the stimuiation is applied in the first few weeks 
after myacardial infarction (9). The electrophysiologic ratio- 
nale for this position is not clear considering that induced 
polymorphic ventricular tachyarrhythmias in the presence of 
ischcmic heart disease ae most likely to be due to reentrant 
excitation, the same mechanism that may also underlie the 
spontaneous arrhythmia. This approach simply highlights 
our limited current understanding of the relation between 
induced polymorphic tachyarrhythmia and its spontaneous 
OCWIW”~~. 
The latter is a form of p&mo~hic ventricular tachycardia 
with a characteristic undulating QRS cantiguration. The 
term torsade de pointes tachycardia should be reserved for 
use with the lonn OTU svndmme (IO). However. not all 
Patients with the-long QTU syndr% have polymorphic 
ventricular tachywdia with a characteristic torsade de 
pointes contigz&n (I I) and this classic contiguration can 
be seen in some padents without the long QTU syndrome. 
The polymorphic ventricular tachycardia seen in patients 
with the acquired long QTU syndrome is characteristically 
bradycardia dependent and is not induced by programmed 
stimulation (IO). There is considerable evidence that at least 
the initiating beats of the tachycardia are due TV early 
afterdepolarizations and triggered activity. There is also 
evidence (12) that the oolvmomhic tachvcardia induced bv 
programmed stimulatidn, .is die to &rant excitation at 
least in the setting of ischemic heart disease. In dogs wi!h 
24-h old myocardird infarction, programmed stimulation 
could induce fast polymorphic ventricular tachycardia that 
sometimes showed the typical lorsade de pointes configure- 
tion and mapping of ventricular activation showed the ar- 
rhythmia to be due to reentrant excitation (12). The varying 
QRS configuration was explained by the changing activation 
pattern of the ventricles from bat to beat because of the 
constant change in the site and configuration of the reentrant 
circuits. Thus, different electrophysiologic mechanisms ran 
give rise to polymorphic ventricular tachycardia under dif. 
fcrent circumstances. 
The preceding discussion is important when trying to 
understand the mechanism by which procainamide can 
chanae an induced oolvmomhic vcnhicul~ tachvcardia to a 
mon&norphic arrh;th&a. bne theoretic possibility is 1: rt 
the polymorphic tachycardia is due to early afterdcpolariza- 
g valid end point. Because~thc ov&dl &ctivcness of 
procainamide in patients with inducible monomorphic ven- 
tricular tachycardia is controversial, it is not advisable to 
routinely extend use of this drug to all patients with induced 
polymorphic ventricular tachycardia. Perhaps its use should 
be reserved for those patients with B high likelihood of 
having the substrate for monomorphic ventricular tachy- 
cardia, such as those with previous myocardial infarction, 
left ventricular aneurysm and an abnormal signal-averaged 
ECG. 
JACC Vol. 21, No. I 
hw.m 1993399-m 
of inductd arrhphmiar and what II the correct rumutalioa protocol? 
Circulation 1%5:7231-7. 
R. Dicarl~ LA Jr. Mom& F, Schwartz AB. et a!. Clinical significance of 
vcnticular fibrikdion.fluttn induced by vcnfricular programmed stimu- 
lmioa. Am Hean I 1985:109:959-63. 
9. Demdss RA, Richards DA, Cody DV. CL al. Pm~~ostic rigoikancc of 
vcnbicular tacbycardia and Eailktian induced at programmed rumula- 
tion and delayed potentials detected in the siwnl averaged elecrrawdi~ 
grams of survivors of acute myocardial itdarclian. Circulation 1%&M 
73145. 
